What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“Seeing my grandmother battle a multitude of cancers (and be alive and well today!) has inspired me.  Through CaNCURE, I get to work in the clinical radiology department at Dana-Farber Cancer Institute to analyze clinical trial data from patients with glioblastoma multiforme (an aggressive brain cancer). My future goals include medical school, where I would like to continue my research and clinical involvement with the brain.”

Amanda Stroiney, Behavioral Neuroscience, ’16


Trainee Spotlight


Holly Chadwick

Behavioral Neuroscience, '23

In vivo investigation of the pathogenesis and development of pituitary adenomas in relation to the loss of MEG3 expression

Valentina Torres

Health Science, '21

Metabolite Quantification from Cancer Tissues using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Catherine Ju-Ying Wu, M.D.

Chief of Division of Stem Cell Transplantation and Cellular Therapies,

Identifies novel immune targets for immune-based therapy of hematologic malignancies. Students will have opportunity to develop and test nanoparticle-based vaccines, alone and in combination with other immunotherapies for cancer treatment.


Ross I Berbeco, Ph.D.

Associate Professor of Radiation Oncology, HMS

Our lab performs theoretical and experimental studies of systemically administered nanoparticles and their role in enhancing radiation therapy for cancer treatment. Students will have the opportunity to functionalize these particles with tumor-specific targeting moieties and study how this leads to localized disruption of the tumor vasculature.


Trainee Spotlight


Rodrigo Blanco Bravo

Bioengineering, '22

Multiplexed cellular fluorescent imaging in head and neck squamous cell carcinomas (HNSCC) for different markers to predict patient specific response rates to immunotherapy and for mapping of the tumor microenvironment (TME).

Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Hannah Curtis

Health Science, '21

The Role of CD8+ and CD4+ in the Tumor Microenvironment (TME) after Controlled Exercise in E0771/M3C Breast Cancer Models


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...